I say keep a close eye on Roche and Genentech.As you may know Genentech shares rose Friday after a published report said Swiss drugmaker Roche was preparing to sweeten its offer to buy the portion of the U.S. biotechnology giant it does not already own.
The Financial Times' Alphaville web site said Roche was preparing to offer about $95 per share, likely ahead of its release of its year-end financial report in early February.
If the deal happens, Roche could win billions of dollars in cancer drug revenue as well as strong R&D. And both are presenters at the conference.
The obama administration insiders say that he will lift the laws and regulations, on biotech research. With genentech leading this sector, i say that it will be up atleast 25% by the end of 2010. Jump now while its cheap.
No comments:
Post a Comment